1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Extended Release Drug Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Sustained Release Drug
1.2.3 Controlled Release Drug
1.3 Market by Application
1.3.1 Global Extended Release Drug Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered 2 Global Growth Trends
2.1 Global Extended Release Drug Market Perspective (2017-2028)
2.2 Extended Release Drug Growth Trends by Region
2.2.1 Extended Release Drug Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Extended Release Drug Historic Market Size by Region (2017-2022)
2.2.3 Extended Release Drug Forecasted Market Size by Region (2023-2028)
2.3 Extended Release Drug Market Dynamics
2.3.1 Extended Release Drug Industry Trends
2.3.2 Extended Release Drug Market Drivers
2.3.3 Extended Release Drug Market Challenges
2.3.4 Extended Release Drug Market Restraints 3 Competition Landscape by Key Players
3.1 Global Top Extended Release Drug Players by Revenue
3.1.1 Global Top Extended Release Drug Players by Revenue (2017-2022)
3.1.2 Global Extended Release Drug Revenue Market Share by Players (2017-2022)
3.2 Global Extended Release Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Extended Release Drug Revenue
3.4 Global Extended Release Drug Market Concentration Ratio
3.4.1 Global Extended Release Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Extended Release Drug Revenue in 2021
3.5 Extended Release Drug Key Players Head office and Area Served
3.6 Key Players Extended Release Drug Product Solution and Service
3.7 Date of Enter into Extended Release Drug Market
3.8 Mergers & Acquisitions, Expansion Plans 4 Extended Release Drug Breakdown Data by Type
4.1 Global Extended Release Drug Historic Market Size by Type (2017-2022)
4.2 Global Extended Release Drug Forecasted Market Size by Type (2023-2028) 5 Extended Release Drug Breakdown Data by Application
5.1 Global Extended Release Drug Historic Market Size by Application (2017-2022)
5.2 Global Extended Release Drug Forecasted Market Size by Application (2023-2028) 6 North America
6.1 North America Extended Release Drug Market Size (2017-2028)
6.2 North America Extended Release Drug Market Size by Country (2017-2022)
6.3 North America Extended Release Drug Market Size by Country (2023-2028)
6.4 United States
6.5 Canada 7 Europe
7.1 Europe Extended Release Drug Market Size (2017-2028)
7.2 Europe Extended Release Drug Market Size by Country (2017-2022)
7.3 Europe Extended Release Drug Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries 8 Asia-Pacific
8.1 Asia-Pacific Extended Release Drug Market Size (2017-2028)
8.2 Asia-Pacific Extended Release Drug Market Size by Country (2017-2022)
8.3 Asia-Pacific Extended Release Drug Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia 9 Latin America
9.1 Latin America Extended Release Drug Market Size (2017-2028)
9.2 Latin America Extended Release Drug Market Size by Country (2017-2022)
9.3 Latin America Extended Release Drug Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil 10 Middle East & Africa
10.1 Middle East & Africa Extended Release Drug Market Size (2017-2028)
10.2 Middle East & Africa Extended Release Drug Market Size by Country (2017-2022)
10.3 Middle East & Africa Extended Release Drug Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE 11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Extended Release Drug Introduction
11.1.4 Pfizer Revenue in Extended Release Drug Business (2017-2022)
11.1.5 Pfizer Recent Development
11.2 Mallinckrodt
11.2.1 Mallinckrodt Company Detail
11.2.2 Mallinckrodt Business Overview
11.2.3 Mallinckrodt Extended Release Drug Introduction
11.2.4 Mallinckrodt Revenue in Extended Release Drug Business (2017-2022)
11.2.5 Mallinckrodt Recent Development
11.3 Teva
11.3.1 Teva Company Detail
11.3.2 Teva Business Overview
11.3.3 Teva Extended Release Drug Introduction
11.3.4 Teva Revenue in Extended Release Drug Business (2017-2022)
11.3.5 Teva Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Extended Release Drug Introduction
11.4.4 Johnson & Johnson Revenue in Extended Release Drug Business (2017-2022)
11.4.5 Johnson & Johnson Recent Development
11.5 Endo Pharmaceuticals
11.5.1 Endo Pharmaceuticals Company Detail
11.5.2 Endo Pharmaceuticals Business Overview
11.5.3 Endo Pharmaceuticals Extended Release Drug Introduction
11.5.4 Endo Pharmaceuticals Revenue in Extended Release Drug Business (2017-2022)
11.5.5 Endo Pharmaceuticals Recent Development
11.6 Purdue Pharma
11.6.1 Purdue Pharma Company Detail
11.6.2 Purdue Pharma Business Overview
11.6.3 Purdue Pharma Extended Release Drug Introduction
11.6.4 Purdue Pharma Revenue in Extended Release Drug Business (2017-2022)
11.6.5 Purdue Pharma Recent Development
11.7 Mylan
11.7.1 Mylan Company Detail
11.7.2 Mylan Business Overview
11.7.3 Mylan Extended Release Drug Introduction
11.7.4 Mylan Revenue in Extended Release Drug Business (2017-2022)
11.7.5 Mylan Recent Development
11.8 Hisamitsu Pharmaceutical
11.8.1 Hisamitsu Pharmaceutical Company Detail
11.8.2 Hisamitsu Pharmaceutical Business Overview
11.8.3 Hisamitsu Pharmaceutical Extended Release Drug Introduction
11.8.4 Hisamitsu Pharmaceutical Revenue in Extended Release Drug Business (2017-2022)
11.8.5 Hisamitsu Pharmaceutical Recent Development
11.9 Sun Pharmaceutical Industries
11.9.1 Sun Pharmaceutical Industries Company Detail
11.9.2 Sun Pharmaceutical Industries Business Overview
11.9.3 Sun Pharmaceutical Industries Extended Release Drug Introduction
11.9.4 Sun Pharmaceutical Industries Revenue in Extended Release Drug Business (2017-2022)
11.9.5 Sun Pharmaceutical Industries Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
